Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02564458 · ClinicalTrials.gov registry record · NA

Fitness in Allogeneic Stem Cell Transplantation

A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT02564458 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02564458, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

Purpose: The primary hypothesis of this study is that the combination of interval exercise training (IET) as well as motivational accelerometry (MA) delivered both as a 5-12 week intervention that will improve cardiorespiratory fitness in patients preparing to undergo allogeneic hematopoietic cell transplantation (alloHCT). MA is not an established term, but in respect to this study, MA refers to the use of wearable accelerometry paired with regular intervals of physical activity coaching from members of the study staff during the IET training. The study will also look at several secondary endpoints including the association of the intervention with changes in cyclin-dependent kinase inhibitor 2A, multiple tumor suppressor 1 (p16INK4a), and the association of the intervention with changes in symptoms and quality of life before and after transplant. Participants: 60 patients will be randomized into two groups, 30 in the intervention group consisting of both IET and MA, and 30 in the control group applying usual care and use of wearable accelerometry without motivational physical activity coaching. Procedures (methods): Results of this study will inform a randomized, multi-site study of a pre-transplant exercise intervention.

Interventions

  • BEHAVIORAL Interval Exercise Training/Motivational Accelerometry

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2015-09
Est. Completion 2018-06
Phase NA

What the Registry Record Tells You About NCT02564458

The ClinicalTrials.gov registry entry for NCT02564458 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Interval Exercise Training/Motivational Accelerometry is the first listed.

NCT02564458 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02564458 about?

NCT02564458 is a clinical study titled "Fitness in Allogeneic Stem Cell Transplantation". Purpose: The primary hypothesis of this study is that the combination of interval exercise training (IET) as well as motivational accelerometry (MA) delivered both as a 5-12 week intervention that will improve cardiorespiratory fitness in patients preparing to undergo allogeneic hematopoietic cell t...

What is the current status of trial NCT02564458?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2015-09. Estimated completion is 2018-06.

What interventions are being tested in trial NCT02564458?

The interventions under investigation include: Interval Exercise Training/Motivational Accelerometry (BEHAVIORAL).

Who is sponsoring clinical trial NCT02564458?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.